Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors.
Amin M, Gao F, Terrero G, Picus J, Wang-Gillam A, Suresh R, Ma C, Tan B, Baggstrom M, Naughton MJ, Trull L, Belanger S, Fracasso PM, Lockhart AC.
Amin M, et al.
Am J Clin Oncol. 2021 Sep 1;44(9):443-448. doi: 10.1097/COC.0000000000000852.
Am J Clin Oncol. 2021.
PMID: 34310349
Clinical Trial.